发明申请
US20050287541A1 Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
有权
用于预测神经母细胞瘤预后的微阵列和预测神经母细胞瘤预后的方法
- 专利标题： Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
- 专利标题（中）： 用于预测神经母细胞瘤预后的微阵列和预测神经母细胞瘤预后的方法
-
申请号： US10947249申请日： 2004-09-23
-
公开(公告)号： US20050287541A1公开(公告)日： 2005-12-29
- 发明人: Akira Nakagawara , Miki Ohira , Shin Ishii , Takeshi Goto , Hiroyuki Kubo , Takahiro Hirata , Yasuko Yoshida , Saichi Yamada
- 申请人： Akira Nakagawara , Miki Ohira , Shin Ishii , Takeshi Goto , Hiroyuki Kubo , Takahiro Hirata , Yasuko Yoshida , Saichi Yamada
- 申请人地址： JP Tosu-shi JP Nagoya-shi JP Chiba-shi
- 专利权人： Hisamitsu Pharmaceutical Co., Inc.,NGK Insulators, Ltd.,Chiba-Prefecture
- 当前专利权人： Hisamitsu Pharmaceutical Co., Inc.,NGK Insulators, Ltd.,Chiba-Prefecture
- 当前专利权人地址： JP Tosu-shi JP Nagoya-shi JP Chiba-shi
- 主分类号： C12M1/34
- IPC分类号： C12M1/34 ; C12Q1/68
摘要：
A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 1 to 96 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 97 to 200 or their partial continuous sequences or their complementary strands.
公开/授权文献
信息查询
